Condition: Central Nervous System Tumour · Arteriovenous Malformation · Sponsor: Uppsala University
Open label, multi-centre prospective study. Adult patients with primary central nervous system tumours fulfilling the inclusion criteria according to the study protocol. The study consists of 2 sequential cohorts evaluated consecutively for the feasibility, safety and toxicity, as well as long-term survival data, when using spot scanning proton beam therapy.
This description comes directly from the study's public registry record.
Petra Witt Nystrom, MD, PhD · petra.witt@akademiska.se
Always discuss trial participation with your own doctor first.
| Sahlgrenska University Hospital | Gothenburg, Sweden | Recruiting |
| Linkoeping University Hospital | Linköping, Sweden | Recruiting |
| Orebro University Hospital | Örebro, Sweden | Recruiting |
| Karolinska University Hospital | Stockholm, Sweden | Recruiting |
| Umea University Hospital | Umeå, Sweden | Recruiting |
| Uppsala University Hospital | Uppsala, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02797366